enobosarm and semaglutide — Topline data
Q1 2027
— Phase 2b PLATEAU clinical trial interim analysis and results on track for calendar Q1 2027 —Source filing
VERU biotech catalysts & pipeline
VERU INC · Data as of 2026-09-08
Upcoming catalysts
enobosarm and semaglutide — Topline data
Q4 2027
Final topline clinical data is expected in the fourth quarter of calendar year 2027.Source filing